Study of tryptophan metabolism via serotonin in cerebrospinal fluid of patients with noncommunicating hydrocephalus using a new endoscopic technique

Journal of Neuroscience Research

Volumn 84, Issue 3, 2006, Pages 683-691

  Comai, Stefano ^a   Longatti, Pierluigi ^a   Perin, Alessandro ^a   Bertazzo, Antonella ^a   Ragazzi, Eugenio ^a   Costa, Carlo V L ^a   Allegri, Graziella ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

CSF; Hydrocephalus; Neuroendoscopy; Serotonin; Tryptophan

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; SEROTONIN; TRYPTOPHAN;

ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; BRAIN AQUEDUCT; BRAIN METABOLISM; BRAIN VENTRICLE; CEREBROSPINAL FLUID ANALYSIS; CHOROID PLEXUS; CISTERNA MAGNA; CLINICAL ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROCEPHALUS; HYPOPHYSIS; INFUNDIBULUM; INTERPEDUNCULAR NUCLEUS; MALE; NEUROENDOSCOPY; NONCOMMUNICATING HYDROCEPHALUS; PINEAL BODY; PRIORITY JOURNAL; SUBARACHNOID SPACE;

5-HYDROXYTRYPTOPHAN; ADULT; AGED; CEREBROSPINAL FLUID; ENDOSCOPY; HUMANS; HYDROCEPHALUS; HYDROXYINDOLEACETIC ACID; LATERAL VENTRICLES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEROTONIN; SUBARACHNOID SPACE; THIRD VENTRICLE; TRYPTOPHAN; VENTRICULOSTOMY;

EID: 33746914413     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20958     Document Type: Article

References (78)

1. Anderson GM. 1991. Signal-to-noise optimization of HPLC-fluorometric systems and their application to the analysis of indoles. Adv Exp Med Biol 294:51-61.
2. Anderson GM, Mefford IN, Tolliver TJ, Riddle MA, Ocame DM, Leckman JF, Cohen DJ. 1990. Serotonin in human lumbar cerebrospinal fluid: a reassessment. Life Sci 46:247-255.
3. Andersson H, Roos BE. 1967. Experimental studies on monoamine metabolites in hydrocephalus. Acta Neurol Scand 43:72-73.
4. Ashcroft GW, Sharman DF. 1960. 5-Hydroxyindoles in human cerebrospinal fluids. Nature 186:1050-1051.
5. Ashcroft GW, Eccleston D, Crawford TB. 1965. 5-Hydroxyindole metabolism in rat brain. A study of intermediate metabolism using the technique of tryptophan loading. I. Methods. J Neurochem 12:483-492.
6. Ashcroft GW, Blackburn IM, Eccleston D, Glen AI, Hartley W, Kinloch NE, Lonergan M, Murray LG, Pullar IA. 1973. 5-Hydroxytryptamine metabolism in affective illness: the effect of tryptophan administration. Psychol Med 3:326-332.
7. Atack C, Bass NH, Lundborg P. 1974. Mechanisms for the elimination of 5-hydroxyindoleacetic acid from brain and cerebrospinal fluid of the rat during postnatal development. Brain Res 30:111-120.
8. Bernheimer H, Birkmayer W, Hornykiewicz O. 1966. Homovanillinsaure in liquor cerebrospinalis: untersuchungen beim Parkinson-Syndrom und anderen ekrankungen des ZNS. Wien Klein Wschr 78:417-419.
9. Chase TN, Gordon EK, Ng LKY. 1973. Norepinephrine metabolism in the CNS of man; studies using 3-methoxy-4-hydroxyphenylethylene glycol levels in CSF. J Neurochem 21:581-587.
10. Coppen A, Brooksbank BW, Peet M. 1972. Tryptophan concentration in the cerebrospinal fluid of depressive patients. Lancet 1:1393.
11. Coppen A, Eccleston EG, Peet M. 1973. Total and free tryptophan concentration in the plasma of depressive patients. Lancet 2:60-63.
12. Costa C, Bettero A, Allegri G. 1987. Rapid measurements of tryptophan, 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in human CSF by selective fluorescence and HPLC. Giorn Ital Clin 12:307-312.
13. Cserr HF, Van Dyke DH. 1971. 5-Hydroxyindoleacetic acid accumulation by isolated choroid plexus. Am J Physiol 220:718-723.
14. Curzon G. 1975. The control of brain tryptophan concentration. Acta Vitaminol Enzymol 29:69-71.
15. Curzon G, Friedel J, Knott PJ. 1973. The effect of fatty acids on the binding of tryptophan to plasma protein. Nature 242:198-200.
16. Curzon G, Friedel J, Katamaneni BD, Greenwood MH, Lader MH. 1974. Unesterified fatty acids and the binding of tryptophan in human plasma. Clin Sci Mol Med 47:415-424.
17. Curzon G, Kantamaneni BD, Bartlett JR, Bridges PK. 1976. Transmitter precursors and metabolites in human ventricular cerebrospinal fluid. J Neurochem 26:613-615.
18. Dahlström A, Fuxe K. 1965. Evidence for the existence of monoamine containing neurons in the central nervous system. II: experimentally induced changes in the intra-neuronal amine levels. Acta Physiol Scand 64(suppl 247):1-36.
19. Davson H. 1968. The cerebrospinal fluid pressure. In: Cumings JN, Kremer M, editors. Biochemical aspects of neurological disorders. Oxford: Blackwell. p 235-249.
20. DeMyer MK, Shea PA, Hendrie HC, Yoshimura NN. 1981. Plasma tryptophan and five other amino acids in depressed and normal subjects. Arch Gen Psychiatry 38:642-646.
21. Ebert MH, Perlow MJ. 1977. Utility of cerebrospinal fluid measurements in studies of brain monoamines. In: Usdin E, Weiner N, Youdim MBH, editors. Structure and function of monoamine enzymes. New York: Marcel Dekker. p 963-984.
22. Eccleston D, Ashcroft GW, Moir ATB, Parker-Rhodes A, Lutz W, O'Mahoney DP. 1968. A comparison of 5-hydroxyindoles in various regions of dog brain and CSF. J Neurochem 15:947-957.
23. Eccleston D, Ashcroft GW, Crawford TB. 1970. Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man. J Neurol Neurosurg Psychiatry 33:269-272.
24. Fernstrom JD, Wurtman RJ. 1971a. Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 173:149-152.
25. Fernstrom JD, Wurtman RJ. 1971b. Brain serotonin content: increase following ingestion of carbohydrate diet. Science 174:1023-1025.
26. Forn J. 1972. Active transport of 5-hydroxyindoleacetic acid by the rabbit choroid plexus in vitro. Blockade by probenecid and metabolic inhibitors. Biochem Pharmacol 21:619-624.
27. Gerbode FA, Bowers MB. 1968. Measurement of acid monoamine metabolites in human and animal cerebrospinal fluid. J Neurochem 15:1053-1055.
28. Garelis E, Sourkes TL. 1973. Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry 36:625-629.
29. Garelis E, Sourkes TL. 1974. Use of cerebrospinal fluid drawn at pneumoencephalography in the study of monoamine metabolism in man. J Neurol Neurosurg Psychiatry 36:704-710.
30. Garelis E, Young SN, Lal S, Sourkes TL. 1974. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies. Brain Res 79:1-8.
31. Gessa GL, Tagliamonte A. 1974. Possibile role of free serum tryptophan in the control of brain tryptophan level and serotonin synthesis. Adv Biochem Psychopharmacol 11:119-131.
32. Gessa GL, Biggio G, Tagliamonte A. 1972. Brain serotonin turnover; dependence on free tryptophan concentration in plasma. Fed Proc 31:2168.
33. Gordon EK, Oliver J. 1971. 3-methoxy-4-hydroxyphenylethylene glycol in human CSF. Clin Chim ACTA 35:145-150.
34. Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A, et al. 1992a. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115:1249-1273.
35. Heyes MP, Saito K, Jacobowitz D, Markey SP, Takikawa O, Vickers JH. 1992b. Poliovirus induces indoleamine-2, 3-dioxygenase and quinolinic acid synthesis in macaque brain. FASEB J 6:2977-2989.
36. Hutson PH, Knott PJ, Curzon G. 1976. Control of brain tryptophan concentration in rats on a high fat diet. Nature 262:142-143.
37. Johansson B, Roos BE. 1975. Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid. Acta Neurol Scand 52:137-144.
38. Jones RFC, Kwok BC, Sterling WA, Vonau M. 1994a. Neuroendoscopic third ventriculostomy. A practical alternative to extracranial shunts in non-communicating hydrocephalus. Acta Neurochir Suppl 61:79-83.
39. Jones RFC, Kwok BC, Stening WA, Vonau M. 1994b. The current status of endoscopic third ventriculostomy in the management of non-communicating hydrocephalus. Minim Invasive Neurosurg 37:28-36.
40. Kehler U, Regelsberger J, Gliemroth J. 2003. Pro and cons of different designs of rigid endoscopes. Minim Invasive Neurosurg 46:205-207.
41. Knott PJ, Curzon G. 1972. Free tryptophan in plasma and brain tryptophan metabolism. Nature 239:452-453.
42. Longatti P, Perin A, Rizzo V, Comai S, Bertazzo A, Allegri G. 2004. Endoscopic selective sampling of human ventricular CSF: a new perspective. Minim Invasive Neurosurg 47:350-354.
43. Massarotti M, Zorzi E, Toffano G. 1974. Concentrations of 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with intracranial hypertension. J Neurosurg Sci 8:47-54.
44. Massarotti M, Migliore A, Roccella P, Toffano G. 1975a. 5-Hydroxyindoleacetic acid (5-HIAA) levels in human CSF as a biochemical approach to the hydrocephalus. Exp Brain Res 23:137.
45. Massarotti M, Roccella P, Tegos S, Toffano G. 1975b. I livelli di 5-HIAA nel liquor ventricolare e lombare di bambini con idrocefalo neoplastico e non neoplastico. L'Arcispedale S. Anna di Ferrara 28:431-437.
46. Massarotti M, Migliore A, Roccella P, Toffano G. 1976. I livelli di 5-HIAA ed HVA nel liquor di pazienti idrocefalici. Acta Neurol 31:601-613.
47. Massarotti M, Roccella P, Toffano G. 1978. 5-Hydroxyindoleacetic acid and homovanillic acid in human cerebrospinal fluid below partial and complete spinal subarachnoid block. Eur Neurol 17:174-180.
48. Massarotti M, Roccela P, Toffano G. 1980. I metaboliti nella patologia midollare con blocco totale e parziale. In: Massarotti M, Toffano G, editors. I metaboliti delle monoamine cerebrali nel liquor. Padova: Liviana Editrice, p 197-207.
49. Maurizi CP. 1991. Recirculation of cerebrospinal fluid through the tela choroidae is why high levels of melatonin can be found in the lateral ventricles. Med Hypoth 35:154-158.
50. Maurizi CP. 2000. A cycle of cerebrospinal fluid: supporting evidence and theoretical considerations. Med Hypoth 54:417-422.
51. Maurizi CP. 2003. The puzzle of where cerebrospinal fluid is absorbed: new pieces. Review. Med Hypoth 60:102-103.
52. McMenamy RH, Lund CC, Oncley JL. 1957. Unbound amino acid concentrations in human blood plasma. J Clin Invest 36:1672-1679.
53. Milhorat TH. 1972. Hydrocephalus and the cerebrospinal fluid. Baltimore: Williams and Wilkins. p 135-137.
54. Milhorat TH. 1975. The third circulation revised. J Neurosurg 42:628-645.
55. Milliken GA, Johnson DE. 1984. Analysis of messy data, vol 1: designed experiments. NewYork: Van Nostrand Reinhold.
56. Moir ATB, Ashcroft GW, Crawford TB, Eccleston D, Guldberg HC. 1970. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain. Brain 93:357-368.
57. Nicoletti F, Raffaele R, Falsaperla A, Paci R. 1981. Circadian variation in 5-hydroxyindoleacetic acid levels in human cerebrospinal fluid. Eur Neurol 20:9-12.
58. Perez-Cruet J, Chase TN, Murphy DL. 1974. Dietary regulation of brain tryptophan metabolism by plasma ratio of free tryptophan and neutral amino acids in humans. Nature 248:693-695.
59. Roccella P, Migliore A, Tegos S, Massarotti M. 1980. I metaboliti nell'indrocefalo. In: Massarotti M, Toffano G, editors. I metaboliti delle monoamine cerebrali nel liquor. Padova: Liviana Editrice. p 161-179.
60. Schmid-Burgk W, Kim JS, Lischewski R, Rassmann W. 1981. Levels of total and free tryptophan in the plasma of endogenous and neurotic depressives. Arch Psychiatr Nervenkr 231:35-39.
61. Schwarcz R. 1993. Metabolism and function of brain kynurenines. Biochem Soc Trans 21:77-82.
62. Schwarcz R, Du F, Schmidt W, Turski WA, Gramsbergen JB, Okuno E, Roberts RC. 1992. Kynurenic acid: a potential pathogen in brain disorders. Ann N Y Acad Sci 648:140-153.
63. Sourkes TL, Young SN, Garelis E, Lal S. 1975. Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF). Acta Vitaminol Enzymol 29:97-99.
64. Tagliamonte A, Tagliamonte P, Perez-Cruet J, Gessa GL. 1971. Increase of brain tryptophan caused by drugs which stimulate serotonin synthesis. Nat New Biol 27:125-126.
65. Tagliamonte A, Biggio G, Vargiu L, Gessa GL. 1973. Free tryptophan in serum controls brain tryptophan level and serotonin synthesis. Life Sci 12:277-287.
66. Teo C. 1998. Third ventriculostomy in the treatment of hydrocephalus: experience with more than 120 cases. In: Hellvig D, Bauer BL, editors. Minimally invasive techniques for neurosurgery. Berlin: Springer-Verlag. p 73-76.
67. Tricoire H, Locatelli A, Chemineau P, Malpaux B. 2002. Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology 143:84-90.
68. Van der Poel FW, van Praag HM, Korf J. 1977. Evidence for a probenecid-sensitive transport system of acid monoamine metabolites from the spinal subarachnoid space. Psychopharmacology 52:35-40.
69. Vapalahti M, Hyyppa MT, Nieminen V, Rinne UK. 1978. Brain monoamine metabolites and tryptophan in ventricular CSF of patients with spasm after aneurysm surgery. J Neurosurg 48:58-63.
70. West KA, Edvinsson L, Nielsen KC, Roos BE. 1972. Concentration of acid monoamine metabolites in ventricular CSF of patients with posterior fossa tumors. In: Brock M, Dietz H, editors. Intracranial Pressure. Berlin: Springer Verlag, p 331-337.
71. Wolfson LI, Katzman R, Esciva A. 1974. Clearence of amine metabolites from the cerebrospinal fluid; the brain as a "sink." Neurology 24:772-779.
72. Young SN, Lal S, Martin JB, Ford RM, Sourkes TL. 1973. 5-Hydroxyindoleacetic acid, homovanillic acid and tryptophan levels in CSF above and below a complete block of CSF flow. Psychiatr Neurol Neurochir 76:439-444.
73. Young SN, Garelis E, Lal S, Martin JB, Molina-Negro P, Ethier R, Sourkes TL. 1974. Tryptophan and 5-hydroxyindoleacetic acid in human cerebrospinal fluid. J Neurochem 22:777-779.
74. Young SN, Etienne P, Sourkes TL. 1976. Relationship between rat brain and cisternal CSF tryptophan concentrations. J Neurol Neurosurg Psychiatry 39:239-243.
75. Young SN, Anderson GM, Gauthier S, Purdy WC. 1980a. The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid. J Neurochem 34:1087-1092.
76. Young SN, Gauthier S, Anderson GM, Purdy WC. 1980b. Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs. J Neurol Neurosurg Psychiatry 43:438-445.
77. Young SN, Gauthier S. 1981. Tryptophan availability and the control of 5-hydroxytryptamine and tryptamine synthesis in human CNS. Adv Exp Med Biol 133:221-230.
78. Young SN, Leyton M, Benkelfat C. 1999. PET studies of serotonin synthesis in the human brain. Adv Exp Med Biol 467:11-18.